The influence of the substrate P 1 position on the specificity of two zinc matrix metalloproteases, membrane type-1 matrix metalloprotease (MT1-MMP) and stromelysin-3 (ST3), was evaluated by synthesizing a series of fluorogenic substrates of general formula dansyl-ProLeu-Ala-Xaa-Trp-Ala-Arg-NH 2 , where Xaa in the P 1 position represents unusual amino acids containing either long arylalkyl or alkyl side chains. Our data demonstrate that both MT1-MMP and ST3 cleave substrates containing in their P 1 position unusual amino acids with extremely long side chains more efficiently than the corresponding substrates with natural phenylalanine or leucine amino acids. In this series of substrates, the replacement of leucine by S-para-methoxybenzyl cysteine increased the k cat /K m ratio by a factor of 37 for MT1-MMP and 9 for ST3. The substrate with a S-paramethoxybenzyl cysteine residue in the P 1 position displayed a k cat /K m value of 1.59 10 6 M ؊1 s ؊1 and 1.67 10 4 M ؊1 s ؊1 , when assayed with MT1-MMP and ST3, respectively. This substrate is thus one of the most rapidly hydrolyzed substrates so far reported for matrixins, and is the first synthetic peptide efficiently cleaved by ST3. These unexpected results for these two matrixins suggest that extracellular proteins may be cleaved by matrixins at sites containing amino acids with unusual long side chains, like those generated in vivo by some post-translational modifications.Matrix metalloproteases (MMPs), 1 also known as matrixins, form a group of structurally related zinc endopeptidases collectively able to degrade all components of the extracellular matrix (1). MMPs are believed to be mediators of both normal and pathological tissue remodeling processes, and their increased expression has been observed in a variety of human disorders (2-4). In particular, membrane type-1 (MT1)-MMP, a progelatinase A activator (5), and stromelysin-3 (ST3), a matrixin with unusual functional properties (6), are expressed in most human carcinomas (7-9). MT1-MMP and ST3 both belong to a subgroup of MMPs which are believed to be intracellularly activated by furin or furin-like convertases, thereby suggesting that MT1-MMP and ST3 are present in tissues in an active form, in contrast to other MMPs which are secreted as inactive zymogens (10 -12). As part of a program aimed at developing therapeutic inhibitors for these two MMPs, the specificity of these enzymes in cleaving synthetic substrates has been investigated. Current data on the specificity of MT1-MMP toward the degradation of synthetic substrates are extremely limited (13), while no synthetic substrate has yet been reported to be cleaved by ST3.In contrast to MT1-MMP and ST3, several studies have been devoted to the delineation of the specificity of other matrixin family members by developing both synthetic substrates (14 -18) and inhibitors for these enzymes (19,20). Such approaches have been greatly facilitated by the resolution of the crystal structures of several MMP catalytic domains (21-27), allowing structure-based desi...